Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


22.03.2021

7 Ann Intern Med
1 Antiviral Res
2 Arch Virol
2 Biochemistry (Mosc)
14 BMJ
2 Epidemiol Infect
8 J Infect
16 J Infect Dis
4 J Virol
9 JAMA
12 Lancet
6 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
3 PLoS Biol
3 PLoS Comput Biol
48 PLoS One
5 Proc Natl Acad Sci U S A
8 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. BHATTACHARYYA A, Sarma P, Kaur H, Medhi B, et al
    Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
    Ann Intern Med. 2021;174:434.
    PubMed        

  2. PAIVA CN, Tausk DV
    Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
    Ann Intern Med. 2021;174:432-433.
    PubMed        

  3. DE CASTRO ARAUJO BL
    Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
    Ann Intern Med. 2021;174:433-434.
    PubMed        

  4. SKIPPER CP, Boulware DR
    Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19.
    Ann Intern Med. 2021;174:434-435.
    PubMed        

  5. CHAGLA Z
    In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    PubMed         Abstract available

  6. ESKIN B
    The AbC-19 Rapid Test had 85% sensitivity and 99% specificity for detecting previous SARS-CoV-2 infection.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    PubMed         Abstract available

  7. CHAGLA Z
    In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 >/=14 d after the 2nd dose.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    PubMed         Abstract available


    Antiviral Res

  8. ROOSENHOFF R, Schutten M, Reed V, Clinch B, et al
    Secondary substitutions in the hemagglutinin and neuraminidase genes associated with neuraminidase inhibitor resistance are rare in the Influenza Resistance Information Study (IRIS).
    Antiviral Res. 2021 Mar 10:105060. doi: 10.1016/j.antiviral.2021.105060.
    PubMed         Abstract available


    Arch Virol

  9. ZINYAKOV NG, Sosipatorova VY, Andriyasov AV, Ovchinnikova EV, et al
    Genetic analysis of genotype G57 H9N2 avian influenza virus isolate A/chicken/Tajikistan/2379/2018 recovered in Central Asia.
    Arch Virol. 2021 Mar 19. pii: 10.1007/s00705-021-05011.
    PubMed         Abstract available

  10. GONZALEZ-GARCIA LD, Martinez-Castillo M, Vargas-Pavia TA, Ulloa-Aguilar JM, et al
    Inhibition of AMP-activated protein kinase in respiratory syncytial virus infection activates lipid metabolism.
    Arch Virol. 2021;166:1177-1182.
    PubMed         Abstract available


    Biochemistry (Mosc)

  11. GAVRILOV LA, Gavrilova NS
    What Can We Learn about Aging and COVID-19 by Studying Mortality?
    Biochemistry (Mosc). 2020;85:1499-1504.
    PubMed         Abstract available

  12. CHERNYAK BV, Popova EN, Prikhodko AS, Grebenchikov OA, et al
    COVID-19 and Oxidative Stress.
    Biochemistry (Mosc). 2020;85:1543-1553.
    PubMed         Abstract available


    BMJ

  13. DYER O
    Covid-19: US Catholics split after bishops' conference recommends against Johnson and Johnson vaccine.
    BMJ. 2021;372:n666.
    PubMed        

  14. MAHASE E
    Covid-19: Booster dose will be needed in autumn to avoid winter surge, says government adviser.
    BMJ. 2021;372:n664.
    PubMed        

  15. CHALLEN R, Brooks-Pollock E, Read JM, Dyson L, et al
    Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study.
    BMJ. 2021;372:n579.
    PubMed         Abstract available

  16. WISE J
    Covid-19: NHS Test and Trace made no difference to the pandemic, says report.
    BMJ. 2021;372:n663.
    PubMed        

  17. GARDINER T, Abraham S, Clymer O, Rao M, et al
    Racial and ethnic health disparities in healthcare settings.
    BMJ. 2021;372:n605.
    PubMed        

  18. MCKEE M
    The UK's PPE procurement scandal reminds us why we need ways to hold ministers to account.
    BMJ. 2021;372:n639.
    PubMed        

  19. MATHEW R
    Rammya Mathew: Workforce must be at the centre of covid-19 recovery plans.
    BMJ. 2021;372:n635.
    PubMed        

  20. DAGLI M
    Covid mutations: honest approach needed from politicians and scientists on pandemic outlook.
    BMJ. 2021;372:n656.
    PubMed        

  21. DIAPER C
    NHS needs more capacity to tackle surgery backlog.
    BMJ. 2021;372:n696.
    PubMed        

  22. FORD T, John A, Gunnell D
    Mental health of children and young people during pandemic.
    BMJ. 2021;372:n614.
    PubMed        

  23. PATEL J, Fernandes G, Sridhar D
    How can we improve self-isolation and quarantine for covid-19?
    BMJ. 2021;372:n625.
    PubMed        


  24. Update to living systematic review on covid-19 in pregnancy.
    BMJ. 2021;372:n615.
    PubMed        

  25. SAHOTA R
    How easy will it really be to replicate the success of the covid-19 vaccine with neglected infectious diseases?
    BMJ. 2021;372:n678.
    PubMed        

  26. ATTAWAY AH, Scheraga RG, Bhimraj A, Biehl M, et al
    Severe covid-19 pneumonia: pathogenesis and clinical management.
    BMJ. 2021;372:n436.
    PubMed         Abstract available


    Epidemiol Infect

  27. TAKEFUJI Y
    Fourier analysis using the number of COVID-19 daily deaths in the US.
    Epidemiol Infect. 2021;149:e64.
    PubMed         Abstract available

  28. BOHM S, Woudenberg T, Chen D, Marosevic DV, et al
    Epidemiology and transmission characteristics of early COVID-19 cases, 20 January-19 March 2020, in Bavaria, Germany.
    Epidemiol Infect. 2021;149:e65.
    PubMed         Abstract available


    J Infect

  29. TOIVONEN L, Karppinen S, Schuez-Havupalo L, Teros-Jaakkola T, et al
    Respiratory syncytial virus infections in children 0-24 months of age in the community.
    J Infect. 2020;80:69-75.
    PubMed         Abstract available

  30. ELKINGTON P, Morgan H
    Personal respirators for population level control of the COVID19 pandemic.
    J Infect. 2020;81:318-356.
    PubMed        

  31. GREEN ST, Cladi L
    High time for an efficient and effective internationally-supported Zoonosis Surveillance System?
    J Infect. 2020;81:647-679.
    PubMed        

  32. TANG JW, Kalliomaki P, Varila TM, Waris M, et al
    Nebulisers as a potential source of airborne virus.
    J Infect. 2020;81:647-679.
    PubMed        

  33. GLATMAN-FREEDMAN A, Kaufman Z, Applbaum Y, Dichtiar R, et al
    Respiratory Syncytial Virus hospitalization burden: a nation-wide population-based analysis, 2000-2017.
    J Infect. 2020;81:297-303.
    PubMed         Abstract available

  34. SCAGNOLARI C, Bitossi C, Frasca F, Viscido A, et al
    Differential toll like receptor expression in cystic fibrosis patients' airways during rhinovirus infection.
    J Infect. 2020;81:726-735.
    PubMed         Abstract available

  35. PANDEY M, Sisodia S, Bandi S, Roland D, et al
    Incidence of spread of clinically relevant SARS-CoV2 infection between children in a tertiary emergency department: An evaluation.
    J Infect. 2020;81:979-997.
    PubMed        

  36. SHAN FZ, Zhu LL, Zhang Y, Tang YH, et al
    Comparison of the role of neutrophil extracellular traps between patients admitted to the intensive care unit with influenza A and B virus infection.
    J Infect. 2021 Mar 15. pii: S0163-4453(21)00121.
    PubMed        


    J Infect Dis

  37. ZUURBIER RP, Bont LJ, Langedijk AC, Hamer M, et al
    Low Sensitivity of BinaxNOW RSV in Infants.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  38. WISEMAN DJ, Thwaites RS, Drysdale SB, Janet S, et al
    Immunological and Inflammatory Biomarkers of Susceptibility and Severity in Adult Respiratory Syncytial Virus Infections.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  39. ZHANG S, Akmar LZ, Bailey F, Rath BA, et al
    Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  40. CHAW PS, Hua L, Cunningham S, Campbell H, et al
    Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  41. CHAW PS, Wong SWL, Cunningham S, Campbell H, et al
    Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  42. SHI T, Ooi Y, Zaw EM, Utjesanovic N, et al
    Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  43. SHI T, Denouel A, Tietjen AK, Campbell I, et al
    Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  44. LIN GL, Golubchik T, Drysdale S, O'Connor D, et al
    Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  45. ONER D, Drysdale SB, McPherson C, Lin GL, et al
    Biomarkers for Disease Severity in Children Infected With Respiratory Syncytial Virus: A Systematic Literature Review.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  46. MILLER M
    Establishing the Value and Strategies for Respiratory Syncytial Virus (RSV) Control: The European RSV Consortium (RESCEU).
    J Infect Dis. 2020;222.
    PubMed        

  47. VAN BOVEN M, Teirlinck AC, Meijer A, Hooiveld M, et al
    Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination.
    J Infect Dis. 2020 Aug 21. pii: 5895295. doi: 10.1093.
    PubMed         Abstract available

  48. REEVES RM, van Wijhe M, Tong S, Lehtonen T, et al
    Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  49. LI Y, Campbell H, Nair H
    Unveiling the Risk Period for Death After Respiratory Syncytial Virus Illness in Young Children Using a Self-Controlled Case Series Design.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  50. WILDENBEEST JG, Zuurbier RP, Korsten K, van Houten MA, et al
    Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  51. JEFFERIES K, Drysdale SB, Robinson H, Clutterbuck EA, et al
    Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).
    J Infect Dis. 2020;222.
    PubMed         Abstract available

  52. CHUNG A, Reeves RM, Nair H, Campbell H, et al
    Hospital Admission Trends for Bronchiolitis in Scotland, 2001-2016: A National Retrospective Observational Study.
    J Infect Dis. 2020;222.
    PubMed         Abstract available


    J Virol

  53. HUMAN S, Hotard AL, Rostad CA, Lee S, et al
    A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
    J Virol. 2020;95.
    PubMed         Abstract available

  54. JENKINS T, Wang R, Harder O, Xue M, et al
    A novel live attenuated RSV vaccine candidate with mutations in the L protein SAM binding site and the G protein cleavage site is protective in cotton rats and a rhesus macaque.
    J Virol. 2020 Nov 11. pii: JVI.01568-20. doi: 10.1128/JVI.01568.
    PubMed         Abstract available

  55. PU J, Yin Y, Liu J, Wang X, et al
    Reassortment with dominant chicken H9N2 influenza virus contributed to the fifth H7N9 virus human epidemic.
    J Virol. 2021 Mar 17. pii: JVI.01578-20. doi: 10.1128/JVI.01578.
    PubMed         Abstract available

  56. DANZY S, Lowen AC, Steel J
    A quantitative approach to assess influenza A virus fitness and transmission in guinea pigs.
    J Virol. 2021 Mar 17. pii: JVI.02320-20. doi: 10.1128/JVI.02320.
    PubMed         Abstract available


    JAMA

  57. MOHANAN M, Malani A, Krishnan K, Acharya A, et al
    Prevalence of SARS-CoV-2 in Karnataka, India.
    JAMA. 2021 Feb 4. pii: 2776292. doi: 10.1001/jama.2021.0332.
    PubMed        

  58. LLOYD EC, Gandhi TN, Petty LA
    Monoclonal Antibodies for COVID-19.
    JAMA. 2021 Feb 5. pii: 2776307. doi: 10.1001/jama.2021.1225.
    PubMed        

  59. BROOKS JT, Butler JC
    Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2.
    JAMA. 2021 Feb 10. pii: 2776536. doi: 10.1001/jama.2021.1505.
    PubMed        

  60. LEAF DE, Ginde AA
    Vitamin D3 to Treat COVID-19: Different Disease, Same Answer.
    JAMA. 2021 Feb 17. pii: 2776736. doi: 10.1001/jama.2020.26850.
    PubMed        

  61. RUBIN R
    The Price of Success-How to Evaluate COVID-19 Vaccines When They're Available Outside of Clinical Trials.
    JAMA. 2021 Feb 18. pii: 2776787. doi: 10.1001/jama.2021.0641.
    PubMed        

  62. ABBASI J
    Saliva Tests Comparable With Nasal Swabs for SARS-CoV-2 Detection.
    JAMA. 2021;325:924.
    PubMed        

  63. ABBASI J
    Prolonged SARS-CoV-2 Infection in a CAR T-Cell Therapy Recipient.
    JAMA. 2021;325:924.
    PubMed        

  64. ABBASI J
    COVID-19 "Liquid Biopsy" Could Offer Monitoring, Prognostic Tool.
    JAMA. 2021;325:924.
    PubMed        

  65. LI L, Neuroth LM, Valachovic E, Schwebel DC, et al
    Association Between Changes in Social Distancing Policies in Ohio and Traffic Volume and Injuries, January Through July 2020.
    JAMA. 2021;325:1003-1006.
    PubMed        


    Lancet

  66. THE LANCET
    Health as a foundation for society.
    Lancet. 2021;397:1.
    PubMed        

  67. FLEISHMAN R
    Dreams deferred.
    Lancet. 2021;396:2083-2084.
    PubMed        

  68. DANIELS JP
    Caribbean rainy season batters health care.
    Lancet. 2021;396:1955.
    PubMed        

  69. MOLLICA RF, Fernando D
    When racial trauma is a chief complaint among health-care staff.
    Lancet. 2020;396:e84.
    PubMed        

  70. CASTRO A
    Maternal and child mortality worsens in Latin America and the Caribbean.
    Lancet. 2020;396:e85.
    PubMed        

  71. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00448.
    PubMed        

  72. BERK J, Brinkley-Rubinstein L, Murphy M, Chan P, et al
    MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00354.
    PubMed        

  73. SISA I, Noblecilla E, Orozco F
    Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00357.
    PubMed        

  74. VOYSEY M, Costa Clemens SA, Madhi SA, Weckx LY, et al
    Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00432.
    PubMed         Abstract available

  75. WHITAKER DK
    UK COVID-19 public inquiry and lessons from patient safety.
    Lancet. 2021 Feb 24. pii: S0140-6736(21)00381.
    PubMed        

  76. USHER AD
    Medical oxygen crisis: a belated COVID-19 response.
    Lancet. 2021;397:868-869.
    PubMed        

  77. HOLT E
    Countries split from EU on COVID-19 vaccines.
    Lancet. 2021;397:958.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  78. MASON M, Welch SB, Arunkumar P, Post LA, et al
    Notes from the Field: Opioid Overdose Deaths Before, During, and After an 11-Week COVID-19 Stay-at-Home Order - Cook County, Illinois, January 1, 2018-October 6, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:362-363.
    PubMed        

  79. BRITTON A, Jacobs Slifka KM, Edens C, Nanduri SA, et al
    Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:396-401.
    PubMed         Abstract available

  80. VOLPP KG, Kraut BH, Ghosh S, Neatherlin J, et al
    Minimal SARS-CoV-2 Transmission After Implementation of a Comprehensive Mitigation Strategy at a School - New Jersey, August 20-November 27, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:377-381.
    PubMed         Abstract available

  81. KRISS JL, Reynolds LE, Wang A, Stokley S, et al
    COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons - United States, December 14, 2020-February 14, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:389-395.
    PubMed         Abstract available

  82. VERLENDEN JV, Pampati S, Rasberry CN, Liddon N, et al
    Association of Children's Mode of School Instruction with Child and Parent Experiences and Well-Being During the COVID-19 Pandemic - COVID Experiences Survey, United States, October 8-November 13, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:369-376.
    PubMed         Abstract available

  83. VAN DYKE ME, Mendoza MCB, Li W, Parker EM, et al
    Racial and Ethnic Disparities in COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25 Years - 16 U.S. Jurisdictions, January 1-December 31, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:382-388.
    PubMed         Abstract available


    N Engl J Med

  84. BYLICKI O, Paleiron N, Janvier F
    An Outbreak of Covid-19 on an Aircraft Carrier.
    N Engl J Med. 2021;384.
    PubMed        

  85. KASPER MR, Geibe JR
    An Outbreak of Covid-19 on an Aircraft Carrier. Reply.
    N Engl J Med. 2021;384.
    PubMed        

  86. ROLLA G, Brussino L, Badiu I
    Maintaining Safety with SARS-CoV-2 Vaccines.
    N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
    PubMed        

  87. CASTELLS MC, Phillips EJ
    Maintaining Safety with SARS-CoV-2 Vaccines. Reply.
    N Engl J Med. 2021 Feb 10. pii: 10.1056/NEJMc2100766.
    PubMed        


    PLoS Biol

  88. COMER SP, Cullivan S, Szklanna PB, Weiss L, et al
    COVID-19 induces a hyperactive phenotype in circulating platelets.
    PLoS Biol. 2021;19:e3001109.
    PubMed         Abstract available

  89. RIHN SJ, Merits A, Bakshi S, Turnbull ML, et al
    A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.
    PLoS Biol. 2021;19:e3001091.
    PubMed         Abstract available

  90. FULWEILER RW, Davies SW, Biddle JF, Burgin AJ, et al
    Rebuild the Academy: Supporting academic mothers during COVID-19 and beyond.
    PLoS Biol. 2021;19:e3001100.
    PubMed         Abstract available


    PLoS Comput Biol

  91. CZUPPON P, Debarre F, Goncalves A, Tenaillon O, et al
    Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action.
    PLoS Comput Biol. 2021;17:e1008752.
    PubMed         Abstract available

  92. LIBIN PJK, Willem L, Verstraeten T, Torneri A, et al
    Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics.
    PLoS Comput Biol. 2021;17:e1008688.
    PubMed         Abstract available

  93. BOUMAN JA, Riou J, Bonhoeffer S, Regoes RR, et al
    Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches.
    PLoS Comput Biol. 2021;17:e1008728.
    PubMed         Abstract available


    PLoS One

  94. FREIDEL MR, Armen RS
    Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
    PLoS One. 2021;16:e0246181.
    PubMed         Abstract available

  95. CONCA W, Alabdely M, Albaiz F, Foster MW, et al
    Serum beta2-microglobulin levels in Coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity?
    PLoS One. 2021;16:e0247758.
    PubMed         Abstract available

  96. AMADU I, Ahinkorah BO, Afitiri AR, Seidu AA, et al
    Assessing sub-regional-specific strengths of healthcare systems associated with COVID-19 prevalence, deaths and recoveries in Africa.
    PLoS One. 2021;16:e0247274.
    PubMed         Abstract available

  97. DEWAU R, Mekonnen TC, Tadesse SE, Muche A, et al
    Knowledge and practice of clients on preventive measures of COVID-19 pandemic among governmental health facilities in South Wollo, Ethiopia: A facility-based cross-sectional study.
    PLoS One. 2021;16:e0247639.
    PubMed         Abstract available

  98. RAYMUNDO CE, Oliveira MC, Eleuterio TA, Andre SR, et al
    Spatial analysis of COVID-19 incidence and the sociodemographic context in Brazil.
    PLoS One. 2021;16:e0247794.
    PubMed         Abstract available

  99. MAIOR CBS, Santana JMM, Lins ID, Moura MJC, et al
    Convolutional neural network model based on radiological images to support COVID-19 diagnosis: Evaluating database biases.
    PLoS One. 2021;16:e0247839.
    PubMed         Abstract available

  100. MARTINEZ D, Parilli C, Scartascini C, Simpser A, et al
    Let's (not) get together! The role of social norms on social distancing during COVID-19.
    PLoS One. 2021;16:e0247454.
    PubMed         Abstract available

  101. SHARMA D, Bouchaud JP, Gualdi S, Tarzia M, et al
    V-, U-, L- or W-shaped economic recovery after Covid-19: Insights from an Agent Based Model.
    PLoS One. 2021;16:e0247823.
    PubMed         Abstract available

  102. ARMSTRONG K, Soltoff A, Rieu-Werden M, Metlay J, et al
    Use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers associated with lower risk of COVID-19 in household contacts.
    PLoS One. 2021;16:e0247548.
    PubMed         Abstract available

  103. POULAIN T, Meigen C, Sobek C, Ober P, et al
    Loss of childcare and classroom teaching during the Covid-19-related lockdown in spring 2020: A longitudinal study on consequences on leisure behavior and schoolwork at home.
    PLoS One. 2021;16:e0247949.
    PubMed         Abstract available

  104. TSO FY, Lidenge SJ, Poppe LK, Pena PB, et al
    Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.
    PLoS One. 2021;16:e0247640.
    PubMed         Abstract available

  105. VECINO-ORTIZ AI, Villanueva Congote J, Zapata Bedoya S, Cucunuba ZM, et al
    Impact of contact tracing on COVID-19 mortality: An impact evaluation using surveillance data from Colombia.
    PLoS One. 2021;16:e0246987.
    PubMed         Abstract available

  106. BOKHARAIE VS
    A study on the effects of containment policies and vaccination on the spread of SARS-CoV-2.
    PLoS One. 2021;16:e0247439.
    PubMed         Abstract available

  107. VELASCO-RODRIGUEZ D, Alonso-Dominguez JM, Vidal Laso R, Lainez-Gonzalez D, et al
    Development and validation of a predictive model of in-hospital mortality in COVID-19 patients.
    PLoS One. 2021;16:e0247676.
    PubMed         Abstract available

  108. WILLIAMS CYK, Townson AT, Kapur M, Ferreira AF, et al
    Interventions to reduce social isolation and loneliness during COVID-19 physical distancing measures: A rapid systematic review.
    PLoS One. 2021;16:e0247139.
    PubMed         Abstract available

  109. MANSOUR Z, Arab J, Said R, Rady A, et al
    Impact of COVID-19 pandemic on the utilization of routine immunization services in Lebanon.
    PLoS One. 2021;16:e0246951.
    PubMed         Abstract available

  110. PIEC I, English E, Thomas MA, Dervisevic S, et al
    Performance of SARS-CoV-2 serology tests: Are they good enough?
    PLoS One. 2021;16:e0245914.
    PubMed         Abstract available

  111. BHOYAR RC, Jain A, Sehgal P, Divakar MK, et al
    High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing.
    PLoS One. 2021;16:e0247115.
    PubMed         Abstract available

  112. HECK TG, Frantz RZ, Frizzo MN, Francois CHR, et al
    Insufficient social distancing may contribute to COVID-19 outbreak: The case of Ijui city in Brazil.
    PLoS One. 2021;16:e0246520.
    PubMed         Abstract available

  113. SEOANE B
    A scaling approach to estimate the age-dependent COVID-19 infection fatality ratio from incomplete data.
    PLoS One. 2021;16:e0246831.
    PubMed         Abstract available

  114. MARTINEZ YA, Guo X, Portales-Perez DP, Rivera G, et al
    The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus.
    PLoS One. 2021;16:e0246901.
    PubMed         Abstract available

  115. NARAVANE AV, Mundae R, Zhou Y, Santilli C, et al
    Short term visual and structural outcomes of anti-vascular endothelial growth factor (anti-VEGF) treatment delay during the first COVID-19 wave: A pilot study.
    PLoS One. 2021;16:e0247161.
    PubMed         Abstract available

  116. DUROSINI I, Triberti S, Savioni L, Pravettoni G, et al
    In the eye of a quiet storm: A critical incident study on the quarantine experience during the coronavirus pandemic.
    PLoS One. 2021;16:e0247121.
    PubMed         Abstract available

  117. GORI MAIA A, Marteleto L, Rodrigues CG, Sereno LG, et al
    The short-term impacts of coronavirus quarantine in Sao Paulo: The health-economy trade-offs.
    PLoS One. 2021;16:e0245011.
    PubMed         Abstract available

  118. MOROKUTTI-KURZ M, Froba M, Graf P, Grosse M, et al
    Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
    PLoS One. 2021;16:e0237480.
    PubMed         Abstract available

  119. KAPLIN A, Junker C, Kumar A, Ribeiro MA, et al
    Evidence and magnitude of the effects of meteorological changes on SARS-CoV-2 transmission.
    PLoS One. 2021;16:e0246167.
    PubMed         Abstract available

  120. TAYLOR S, Asmundson GJG
    Negative attitudes about facemasks during the COVID-19 pandemic: The dual importance of perceived ineffectiveness and psychological reactance.
    PLoS One. 2021;16:e0246317.
    PubMed         Abstract available

  121. WU M, Whittemore K, Huang CC, Corrado RE, et al
    Community-setting pneumonia-associated hospitalizations by level of urbanization-New York City versus other areas of New York State, 2010-2014.
    PLoS One. 2020;15:e0244367.
    PubMed         Abstract available

  122. KIRPICH A, Koniukhovskii V, Shvartc V, Skums P, et al
    Development of an interactive, agent-based local stochastic model of COVID-19 transmission and evaluation of mitigation strategies illustrated for the state of Massachusetts, USA.
    PLoS One. 2021;16:e0247182.
    PubMed         Abstract available

  123. SOWDEN R, Borgstrom E, Selman LE
    'It's like being in a war with an invisible enemy': A document analysis of bereavement due to COVID-19 in UK newspapers.
    PLoS One. 2021;16:e0247904.
    PubMed         Abstract available

  124. HIGGINS RL, Rawlings SA, Case J, Lee FY, et al
    Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG lateral flow assay.
    PLoS One. 2021;16:e0247797.
    PubMed         Abstract available

  125. GEBRESELASSIE AF, Bekele A, Tatere HY, Wong R, et al
    Assessing the knowledge, attitude and perception on workplace readiness regarding COVID-19 among health care providers in Ethiopia-An internet-based survey.
    PLoS One. 2021;16:e0247848.
    PubMed         Abstract available

  126. MAZZARELLI A, Giancola ML, Farina A, Marchioni L, et al
    16S rRNA gene sequencing of rectal swab in patients affected by COVID-19.
    PLoS One. 2021;16:e0247041.
    PubMed         Abstract available

  127. BARUTCU ATAS D, Aydin Sunbul E, Velioglu A, Tuglular S, et al
    The association between perceived stress with sleep quality, insomnia, anxiety and depression in kidney transplant recipients during Covid-19 pandemic.
    PLoS One. 2021;16:e0248117.
    PubMed         Abstract available

  128. SHEN Q, Tao Y
    Stance markers in English medical research articles and newspaper opinion columns: A comparative corpus-based study.
    PLoS One. 2021;16:e0247981.
    PubMed         Abstract available

  129. SCHRANZ M, Georgopoulos M, Sacu S, Reumueller A, et al
    Incidence and surgical care of retinal detachment during the first SARS-CoV-2 lockdown period at a tertiary referral center in Austria.
    PLoS One. 2021;16:e0248010.
    PubMed         Abstract available

  130. ZHANG J, Feng B, Wu Y, Xu P, et al
    The effect of human mobility and control measures on traffic safety during COVID-19 pandemic.
    PLoS One. 2021;16:e0243263.
    PubMed         Abstract available

  131. KUSTER AC, Overgaard HJ
    A novel comprehensive metric to assess effectiveness of COVID-19 testing: Inter-country comparison and association with geography, government, and policy response.
    PLoS One. 2021;16:e0248176.
    PubMed         Abstract available

  132. ALAM GMM, Khatun MN
    Impact of COVID-19 on vegetable supply chain and food security: Empirical evidence from Bangladesh.
    PLoS One. 2021;16:e0248120.
    PubMed         Abstract available

  133. FRUEHWIRTH JC, Biswas S, Perreira KM
    The Covid-19 pandemic and mental health of first-year college students: Examining the effect of Covid-19 stressors using longitudinal data.
    PLoS One. 2021;16:e0247999.
    PubMed         Abstract available

  134. XU Z, Wu B, Topcu U
    Control strategies for COVID-19 epidemic with vaccination, shield immunity and quarantine: A metric temporal logic approach.
    PLoS One. 2021;16:e0247660.
    PubMed         Abstract available

  135. YOKOYAMA R, Kurano M, Morita Y, Shimura T, et al
    Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    PLoS One. 2021;16:e0247711.
    PubMed         Abstract available

  136. BOOTH A, Reed AB, Ponzo S, Yassaee A, et al
    Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis.
    PLoS One. 2021;16:e0247461.
    PubMed         Abstract available

  137. CHEVALLIER LUGON C, Smit M, Salamun J, Abderrahmane M, et al
    Novel outpatient management of mild to moderate COVID-19 spares hospital capacity and safeguards patient outcome: The Geneva PneumoCoV-Ambu study.
    PLoS One. 2021;16:e0247774.
    PubMed         Abstract available

  138. XUE B, McMunn A
    Gender differences in unpaid care work and psychological distress in the UK Covid-19 lockdown.
    PLoS One. 2021;16:e0247959.
    PubMed         Abstract available

  139. ZHANG M, Li L, Luo M, Liang B, et al
    Genomic characterization and evolution of SARS-CoV-2 of a Canadian population.
    PLoS One. 2021;16:e0247799.
    PubMed         Abstract available

  140. MAJAM M, Fischer A, Phiri J, Venter F, et al
    International citizen project to assess early stage adherence to public health measures for COVID-19 in South Africa.
    PLoS One. 2021;16:e0248055.
    PubMed         Abstract available

  141. CARTAXO ANS, Barbosa FIC, de Souza Bermejo PH, Moreira MF, et al
    The exposure risk to COVID-19 in most affected countries: A vulnerability assessment model.
    PLoS One. 2021;16:e0248075.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  142. MENDELS DA, Dortet L, Emeraud C, Oueslati S, et al
    Using artificial intelligence to improve COVID-19 rapid diagnostic test result interpretation.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  143. SINGH S, Shaikh M, Hauck K, Miraldo M, et al
    Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  144. LI K, Jacob DJ, Liao H, Qiu Y, et al
    Ozone pollution in the North China Plain spreading into the late-winter haze season.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  145. LIU Y, Hu G, Wang Y, Ren W, et al
    Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  146. KIZILCEC RF, Makridis CA, Sadowski KC
    Pandemic response policies' democratizing effects on online learning.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Vaccine

  147. STURKENBOOM M, Bahri P, Chiucchiuini A, Grove Krause T, et al
    Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.
    Vaccine. 2019 Oct 31. pii: S0264-410X(19)31002.
    PubMed         Abstract available

  148. GIESE H, Neth H, Moussaid M, Betsch C, et al
    The echo in flu-vaccination echo chambers: Selective attention trumps social influence.
    Vaccine. 2019 Dec 18. pii: S0264-410X(19)31563.
    PubMed         Abstract available

  149. BELL S, Chantler T, Paterson P, Mounier-Jack S, et al
    Is flu vaccination opt-out feasible? Evidence from vaccination programme implementers and managers in the English National Health Service.
    Vaccine. 2020 May 4. pii: S0264-410X(20)30506.
    PubMed         Abstract available

  150. CHOI UY, Kim KH, Lee KY, Kim JH, et al
    Active-controlled phase III study of an egg-cultivated quadrivalent inactivated split-virion influenza vaccine (GC3110A) in healthy Korean children aged 6-35 months.
    Vaccine. 2021 Mar 15. pii: S0264-410X(21)00273.
    PubMed         Abstract available

  151. LEE J, Li Y, Li Y, Cino-Ozuna AG, et al
    Bat influenza vectored NS1-truncated live vaccine protects pigs against heterologous virus challenge.
    Vaccine. 2021 Mar 11. pii: S0264-410X(21)00268.
    PubMed         Abstract available

  152. BERTRAN K, Kassa A, Criado MF, Nunez IA, et al
    Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.
    Vaccine. 2021 Mar 11. pii: S0264-410X(21)00266.
    PubMed         Abstract available

  153. STURM L, Kasting ML, Head KJ, Hartsock JA, et al
    Influenza vaccination in the time of COVID-19: A national U.S. survey of adults.
    Vaccine. 2021 Mar 4. pii: S0264-410X(21)00271.
    PubMed         Abstract available

  154. EBAMA MS, Chu SY, Azziz-Baumgartner E, Lafond KE, et al
    Ancillary benefits of seasonal influenza vaccination in middle-income countries.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00228.
    PubMed         Abstract available


    Virology

  155. WOLF JJ, Xia C, Studstill CJ, Ngo H, et al
    Influenza A virus NS1 induces degradation of sphingosine 1-phosphate lyase to obstruct the host innate immune response.
    Virology. 2021;558:67-75.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: